Hospira (HSP)

Add to Watchlists Create an Alert
35.18 -0.22  -0.62%   NYSE May 23, 8:00PM BATS Real time Currency in USD

Hospira Retained Earnings Quarterly YoY Growth:

-3.77% for March 31, 2013
View Full Chart

Hospira Retained Earnings Quarterly YoY Growth Chart

    Hospira Historical Retained Earnings Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -3.77%
    Dec. 31, 2012 2.34%
    Sept. 30, 2012 -8.33%
    June 30, 2012 -12.10%
    March 31, 2012 -5.82%
    Dec. 31, 2011 -0.50%
    Sept. 30, 2011 14.44%
    June 30, 2011 24.10%
    March 31, 2011 21.73%
    Dec. 31, 2010 23.19%
    Sept. 30, 2010
    June 30, 2010
    March 31, 2010 29.20%
    Dec. 31, 2009 35.55%
    Sept. 30, 2009
    June 30, 2009
       
    March 31, 2009 47.77%
    Dec. 31, 2008 39.33%
    Sept. 30, 2008 39.54%
    June 30, 2008 39.70%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro

    About Retained Earnings Growth

    Retained Earnings Growth is the percent increase/decrease of a company's retained net income over time. A company can use retained earnings to maintain current operations, or to invest in new ventures. Generally speaking, retained earnings growth is accompanied by subsequent increases in sales and profitability.

    If a company's retained earnings at the end of 2008 were $12 million, and by the end of 2009 the company's retained earnings increased to $15 million, the company experienced a retained earnings growth of 25%.
    Learn More

    Get data for

    HSP Retained Earnings Quarterly YoY Growth Benchmarks

    Companies
    Durect Corporation
    Cumberland Pharmaceuticals 47.97%
    Cubist Pharmaceuticals

    HSP Retained Earnings Quarterly YoY Growth Range, Past 5 Years

    Minimum -12.10% Jun 2012
    Maximum 47.77% Mar 2009
    Average 17.90%